Liver Repair

Levičar, Nataša; Pai, Madhava; Habib, Nagy

doi:10.1142/9781848161832_0029

Search citation statements

Order By: Relevance

Paper Sections

Select...

For Liver Diseases Ceived Transplantation Of Oval Cells Tran1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2009

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five patients were included and submitted to all the study tients remained without complications or adverse events related to the procedure and the partial improvement of phases. The patients received 520 µg of G-CSF during 5 days and then were subjected to leukopheresis to obliver function lasted approximately 12 months (64). A recently published study by Pai et al evaluated the tain the CD34 + on day 5.…”

Section: For Liver Diseases Ceived Transplantation Of Oval Cells Tranmentioning

confidence: 99%

Current Status of Stem Cell Therapy for Liver Diseases

et al. 2009

View full text Add to dashboard Cite

Liver failure is one of the main causes of death worldwide and is a growing health problem. Since the discovery of stem cell populations capable of differentiating into specialized cell types, including hepatocytes, the possibility of their utilization in the regeneration of the damaged liver has been a focus of intense investigation. A variety of cell types were tested both in vitro and in vivo, but the definition of a more suitable cell preparation for therapeutic use in each type of liver lesions is yet to be determined. Here we review the protocols described for differentiation of stem cells into hepatocytes, the results of cell therapy in animal models of liver diseases, as well as the available data of the clinical trials in patients with advanced chronic liver disease.

show abstract

Section: For Liver Diseases Ceived Transplantation Of Oval Cells Tranmentioning

confidence: 99%